Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2998356rdf:typepubmed:Citationlld:pubmed
pubmed-article:2998356lifeskim:mentionsumls-concept:C0007600lld:lifeskim
pubmed-article:2998356lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:2998356lifeskim:mentionsumls-concept:C0034802lld:lifeskim
pubmed-article:2998356lifeskim:mentionsumls-concept:C0007137lld:lifeskim
pubmed-article:2998356lifeskim:mentionsumls-concept:C0017636lld:lifeskim
pubmed-article:2998356lifeskim:mentionsumls-concept:C1518174lld:lifeskim
pubmed-article:2998356pubmed:issue1lld:pubmed
pubmed-article:2998356pubmed:dateCreated1985-12-13lld:pubmed
pubmed-article:2998356pubmed:abstractTextTwo established human tumor cell lines, epidermoid carcinoma line A431 and glioblastoma line SF268, were studied to compare the interaction of each with epidermal growth factor (EGF). SF268 cells bound [125I] EGF with 35-40 fold higher affinity than did the A431 cells. The EGF binding sites of both lines were photoaffinity labeled using 2,4-NAPS-[125I] EGF, a photoreactive derivative of EGF. Extracts of photolysed cells analyzed by SDS-PAGE showed a difference between the two cell lines in the high molecular weight component corresponding to the EGF receptor. EGF in a dose range from 0.3-200 nM had no effect on thymidine incorporation by SF268 cells, whereas thymidine incorporation by A431 cells was markedly inhibited by EGF.lld:pubmed
pubmed-article:2998356pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2998356pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2998356pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2998356pubmed:languageenglld:pubmed
pubmed-article:2998356pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2998356pubmed:citationSubsetIMlld:pubmed
pubmed-article:2998356pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2998356pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2998356pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2998356pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2998356pubmed:statusMEDLINElld:pubmed
pubmed-article:2998356pubmed:monthOctlld:pubmed
pubmed-article:2998356pubmed:issn0006-291Xlld:pubmed
pubmed-article:2998356pubmed:authorpubmed-author:WestphalMMlld:pubmed
pubmed-article:2998356pubmed:authorpubmed-author:RosenblumM...lld:pubmed
pubmed-article:2998356pubmed:authorpubmed-author:HammondsR...lld:pubmed
pubmed-article:2998356pubmed:authorpubmed-author:HarshG RGR4thlld:pubmed
pubmed-article:2998356pubmed:issnTypePrintlld:pubmed
pubmed-article:2998356pubmed:day15lld:pubmed
pubmed-article:2998356pubmed:volume132lld:pubmed
pubmed-article:2998356pubmed:ownerNLMlld:pubmed
pubmed-article:2998356pubmed:authorsCompleteYlld:pubmed
pubmed-article:2998356pubmed:pagination284-9lld:pubmed
pubmed-article:2998356pubmed:dateRevised2009-11-19lld:pubmed
pubmed-article:2998356pubmed:meshHeadingpubmed-meshheading:2998356-...lld:pubmed
pubmed-article:2998356pubmed:meshHeadingpubmed-meshheading:2998356-...lld:pubmed
pubmed-article:2998356pubmed:meshHeadingpubmed-meshheading:2998356-...lld:pubmed
pubmed-article:2998356pubmed:meshHeadingpubmed-meshheading:2998356-...lld:pubmed
pubmed-article:2998356pubmed:meshHeadingpubmed-meshheading:2998356-...lld:pubmed
pubmed-article:2998356pubmed:meshHeadingpubmed-meshheading:2998356-...lld:pubmed
pubmed-article:2998356pubmed:meshHeadingpubmed-meshheading:2998356-...lld:pubmed
pubmed-article:2998356pubmed:meshHeadingpubmed-meshheading:2998356-...lld:pubmed
pubmed-article:2998356pubmed:meshHeadingpubmed-meshheading:2998356-...lld:pubmed
pubmed-article:2998356pubmed:meshHeadingpubmed-meshheading:2998356-...lld:pubmed
pubmed-article:2998356pubmed:meshHeadingpubmed-meshheading:2998356-...lld:pubmed
pubmed-article:2998356pubmed:meshHeadingpubmed-meshheading:2998356-...lld:pubmed
pubmed-article:2998356pubmed:meshHeadingpubmed-meshheading:2998356-...lld:pubmed
pubmed-article:2998356pubmed:meshHeadingpubmed-meshheading:2998356-...lld:pubmed
pubmed-article:2998356pubmed:year1985lld:pubmed
pubmed-article:2998356pubmed:articleTitleEpidermal growth factor receptors in the human glioblastoma cell line SF268 differ from those in epidermoid carcinoma cell line A431.lld:pubmed
pubmed-article:2998356pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2998356pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:2998356pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:2998356pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2998356lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2998356lld:pubmed